Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: Pogeu Mahone who wrote (183782)	2/10/2022 3:24:48 PM
From: maceng2	Read Replies (1) \| Respond to of 217765

When it comes to Pfizer issues yes. The reason being Jim Smith. In the tweet, Malone showed the LinkedIn profile of Jim Smith: “Jim Smith, who sits on Pfizer’s board, is also former president and current chairman of the Thomson Reuters Foundation, and CEO and director of Reuters parent company, Thomson Reuters Corporation — a $1.53 billion publicly traded “ provider of financial information … to businesses, governments and individuals worldwide.” Conflict of Interest: Reuters ‘Fact Checks’ COVID-Related Social Media Posts, But Fails to Disclose Ties to Pfizer, World Economic Forum • Children's Health Defense (childrenshealthdefense.org)